Reversal of rocuronium-induced fixed pupillary dilation by sugammadex in ICU patients with COVID-19

Br J Anaesth. 2024 Mar;132(3):627-629. doi: 10.1016/j.bja.2023.12.011. Epub 2024 Jan 12.

¹ Intensive Care Unit, CHIREC Hospital Group, Université Libre de Bruxelles, Brussels, Belgium; Intensive Care Unit, CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: maxime.winant@stpierre-bru.be.
² Intensive Care Unit, CHIREC Hospital Group, Université Libre de Bruxelles, Brussels, Belgium.
³ Department of Ophthalmology, CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium.
⁴ Intensive Care Unit, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.

No abstract available

Keywords: COVID-19 ARDS; pupillary dilation; rocuronium infusion; rocuronium side-effect; sugammadex reversal.

Publication types